News
White House releases letter from Biden’s doctor after questions about Parkinson’s specialist’s White House visits
Washington — The White House released a letter from President Biden’s doctor Monday night after press secretary Karine Jean-Pierre faced repeated questions at a briefing earlier in the day about Mr. Biden’s health and whether visits to the White House by a Parkinson’s disease specialist involved the president.
White House visitor logs, details of which were first reported by the New York Post and New York Times, show that Dr. Kevin Cannard, an expert on Parkinson’s disease, visited the White House eight times from last summer to this spring. The logs show Cannard met at least once with Mr. Biden’s personal physician.
Jean-Pierre told reporters Monday afternoon that the president is not being treated for Parkinson’s.
“Has the president been treated for Parkinson’s? No. Is he being treated for Parkinson’s? No, he’s not. Is he taking medication for Parkinson’s? No,” she said.
But at the time, the press secretary refused to confirm the doctor’s visits, citing “security reasons.”
It led to a tense back-and-forth between Jean-Pierre and reporters. It came as the president holds firm against critics who have urged him to end his reelection campaign after a disastrous debate performance against former President Donald Trump on June 27.
“You’re not answering a very basic, direct question” about the doctor’s visits, CBS News’ Ed O’Keefe said to Jean-Pierre.
“Every year, around the president’s physical examination, he sees a neurologist,” she said. “That’s three times.”
“At the White House or Walter Reed?” O’Keefe asked, referring to Walter Reed National Military Medical Center, where presidents typically receive their annual physical exam. Mr. Biden had a checkup there in February.
“That is what I’m sharing with you. So every time he has a physical, he has had to see a neurologist. So that is answering that question,” Jean-Pierre said.
“Did Dr. Kevin Cannard come to the White House specifically because of the president’s condition?” O’Keefe asked again.
“For security reasons, we cannot share names,” the press secretary said. “We cannot share names of specialists broadly, from a dermatologist to a neurologist.”
CBS News noted the visits were public information, but Jean-Pierre said she could not confirm the visits because “we have to keep their privacy.”
“It doesn’t matter how hard you push me. It doesn’t matter how angry you get with me. I’m not going to confirm a name. It doesn’t matter if it’s even in the log,” she said. “It is inappropriate. It is not acceptable. So I’m not going to do it.”
Monday night, the White House released a memo from the president’s physician, Dr. Kevin O’Connor, in which he said he had obtained permission from President Biden and Dr. Cannard to share more details.
“Dr. Cannard was the neurological specialist that examined President Biden for each of his annual physicals. His findings have been made public each time I have released the results of the President’s annual physical. President Biden has not seen a neurologist outside of his annual physical,” O’Connor wrote, noting that Cannard has been the neurology consultant to the White House Medical Unit since 2012.
“The results of this year’s exam were detailed in my February 28th letter: ‘An extremely detailed neurologic exam was again reassuring in that there were no findings which would be consistent with any cerebellar or other central neurological disorder, such as stroke, multiple sclerosis, Parkinson’s, or ascending lateral sclerosis,” O’Connor wrote.
O’Connor also noted that Cannard has made regular visits to the White House Medical Unit “in support of the thousands of active-duty members assigned in support of White House operations. Many military personnel experience neurological issues related to their service, and Dr. Cannard regularly visits the WHMU as part of this General Neurology practice.”
The president, adamant that he’s staying in the race, has gone on offense in recent days.
Since the debate, Mr. Biden has been trying to prove he can do the job for another four years, participating in a number of interviews, campaign events and making outreach to prominent Democrats and donors in an effort to shore up support.
“I am not going anywhere,” Mr. Biden said in a phone interview with MSNBC’s “Morning Joe” on Monday. “I wouldn’t be running if I didn’t absolutely believe that I am the best candidate to beat Donald Trump in 2024. We had a Democratic nominating process where the voters spoke clearly.”
In a letter to congressional Democrats on Monday, Mr. Biden said he is “firmly committed” to continuing his campaign and called for the discourse on whether he has a path forward to end.
First lady Jill Biden, seen as one of the few who might be able to sway his decision, echoed his message during a campaign stop in Wilmington, North Carolina.
“Joe has made it clear that he is all in,” she said. “That’s the decision that he’s made, and just as he has always supported my career, I am all in too.”
Though several House Democrats have called for him to withdraw from the race, many have said they’re still backing him. No Senate Democrats have publicly called for the president to step aside, though some have urged him to do more to show he’s up to the task.
Among those wanting Mr. Biden to withdraw is Washington Rep. Adam Smith, who told CBS News on Monday, “there would be a huge sigh of relief amongst just about every Democrat in the House” if the president ends his campaign.
“We would be better off with another nominee,” Smith said. “I believe that in my heart, my soul, my brain — I’m 100% convinced of that.”
A recent CBS News poll found that the race shifted slightly in former President Donald Trump’s direction after the July 27 debate. Trump now has a 3-point edge over Mr. Biden in battleground states and a 2-point lead nationally.
One observer of the current Senate race in Louisiana noted that Sen. Bill Cassidy could lose his reelection bid.
Annie Flanagan for NPR
hide caption
toggle caption
Annie Flanagan for NPR
Sen. Bill Cassidy lost Saturday’s Louisiana Republican primary according to a race call by the Associated Press.
Cassidy, who served two terms in the Senate, was one of seven Republican senators who voted to convict President Trump after the January 6th insurrection at the Capitol. That vote put him at odds with Trump and his MAGA coalition, ultimately leading Trump to push Rep. Julia Letlow to run against Cassidy.
Cassidy’s bid for a third term was viewed as a test of Trump’s grip on the party–and of what voters want from their representatives in Washington. The primary pitted Cassidy, a veteran lawmaker, former physician and chair of the powerful Senate health committee, against Letlow, a political newcomer and a millennial MAGA loyalist.
A detailed view of a hat that reads, Run Julia Run, is seen at a campaign event for Rep. Julia Letlow (R-LA) on May 6, 2026 in Franklinton, Louisiana.
Tyler Kaufman/Getty Images
hide caption
toggle caption
Tyler Kaufman/Getty Images
A former college administrator, Letlow won a special election in 2021 for the House seat her late husband, Luke, was set to assume before he died from COVID in 2020.
In Congress, Letlow sponsored a bill to collect oral histories from the pandemic and has focused on education and children. She introduced the “Parents Bill of Rights Act,” which would allow parents to review classroom materials like library books and require schools to notify parents if their child requests different pronouns, locker rooms or sports teams.
She also serves on the powerful appropriations committee and has embraced Trump’s agenda.
Letlow, who came first in Saturday’s primary, will face Louisiana state Treasurer John Fleming in the runoff on June 27. Cassidy came in third.
The election result is a victory for President Trump who has put Republican loyalty to the test on the ballot so far this year in Indiana state senate primaries and in Cassidy’s race.
Another major test of Trump’s influence comes in Kentucky’s primary on Tuesday when Republican Rep. Thomas Massie, who has found himself at odds with the president, faces a challenger endorsed by Trump.
News
Brass bands in Beijing make way for sticker shock at home as Trump returns to escalating inflation
WASHINGTON (AP) — President Donald Trump returned from the spectacle of a Chinese state visit to a less than welcoming U.S. economy — with the military band and garden tour in Beijing giving way to pressure over how to fix America’s escalating inflation rate.
Consumer inflation in the United States increased to 3.8% annually in April, higher than what he inherited as the Iran war and the Republican president’s own tariffs have pushed up prices. Inflation is now outpacing wage gains and effectively making workers poorer. The Cleveland Federal Reserve estimates that annual inflation could reach 4.2% in May as the war has kept oil and gasoline prices high.
Trump’s time with Chinese leader Xi Jinping appears unlikely to help the U.S. economy much, despite Trump’s claims of coming trade deals. The trip occurred as many people are voting in primaries leading into the November general election while having to absorb the rising costs of gasoline, groceries, utility bills, jewelry, women’s clothing, airplane tickets and delivery services. Democrats see the moment as a political opportunity.
“He’s returning to a dumpster fire,” said Lindsay Owens, executive director of Groundwork Collaborative, a liberal think tank focused on economic issues. “The president will not have the faith and confidence of the American people — the economy is their top issue and the president is saying, ‘You’re on your own.’”
The president’s trip to Beijing and his recent comments that indicated a tone-deafness to voters’ concerns about rising prices have suggested his focus is not on the American public and have undermined Republicans who had intended to campaign on last year’s tax cuts as helping families.
Trump described the trip as a victory, saying on social media that Xi “congratulated me on so many tremendous successes,” as the U.S. president has praised their relationship.
Trump told reporters that Boeing would be selling 200 aircraft — and maybe even 750 “if they do a good job” — to the Chinese. He said American farmers would be “very happy” because China would be “buying billions of dollars of soybeans.”
“We had an amazing time,” Trump said as he flew home on Air Force One, and told Fox News’ Bret Baier in an interview that gasoline prices were just some “short-term pain” and would “drop like a rock” once the war ends.
Inflationary pain is not a factor in how Trump handles Iran
Trump departed from the White House for China by saying the negotiations over the Iran war depended on stopping Tehran from developing nuclear weapons. “I don’t think about Americans’ financial situation. I don’t think about anybody. I think about one thing: We cannot let Iran have a nuclear weapon,” Trump said.
That remark prompted blowback because it suggested to some that Trump cared more about challenging Iran than fighting inflation at home. Trump defended his words, telling Fox News: “That’s a perfect statement. I’d make it again.”
The White House has since stressed that Trump is focused on inflation.
Asked later about the president’s words, Vice President JD Vance said there had been a “misrepresentation” of the remarks. White House spokesman Kush Desai said the “administration remains laser-focused on delivering growth and affordability on the homefront” while indicating actions would be taken on grocery prices.
But as Trump appeared alongside Xi, new reports back home showed inflation rising for businesses and interest rates climbing on U.S. government debt.
His comments that Boeing would sell 200 jets to China caused the company’s stock price to fall because investors had expected a larger number. There was little concrete information offered about any trade agreements reached during the summit, including Chinese purchases of U.S. exports such as liquefied natural gas and beef.
“Foreign policy wins can matter politically, but only if voters feel stability and affordability in their daily lives,” said Brittany Martinez, a former Republican congressional aide who is the executive director of Principles First, a center-right advocacy group focused on democracy issues.
“Midterms are almost always a referendum on cost of living and public frustration, and Republicans are not immune from the same inflation and affordability pressures that hurt Democrats in recent cycles,” she added.
Democrats see Trump as vulnerable
Democratic lawmakers are seizing on Trump’s comments before his trip as proof of his indifference to lowering costs. There is potential staying power of his remarks as Americans head into Memorial Day weekend facing rising prices for the hamburgers and hot dogs to be grilled.
“What Americans do not see is any sympathy, any support, or any plan from Trump and congressional Republicans to lower costs – in fact, they see the opposite,” Senate Democratic leader Chuck Schumer of New York said Thursday.
Vance faulted the Biden administration for the inflation problem even though the inflation rate is now higher than it was when Trump returned to the White House in January 2025 with a specific mandate to fix it.
“The inflation number last month was not great,” Vance said Wednesday, but he then stressed, “We’re not seeing anything like what we saw under the Biden administration.”
Inflation peaked at 9.1% in June 2022 under Biden, a Democrat. By the time Trump took the oath of office, it was a far more modest 3%.
Trump’s inflation challenge could get harder
The data tells a different story as higher inflation is spreading into the cost of servicing the national debt.
Over the past week, the interest rate charged on 10-year U.S. government debt jumped from 4.36% to 4.6%, an increase that implies higher costs for auto loans and mortgages.
“My fear is that the layers of supply shocks that are affecting the U.S. economy will only further feed into inflationary pressures,” said Gregory Daco, chief economist at EY-Parthenon.
Daco noted that last year’s tariff increases were now translating into higher clothing prices. With the Supreme Court ruling against Trump’s ability to impose tariffs by declaring an economic emergency, his administration is preparing a new set of import taxes for this summer.
Daco stressed that there have been a series of supply shocks. First, tariffs cut into the supply of imports. In addition, Trump’s immigration crackdown cut into the supply of foreign-born workers. Now, the effective closure of the Strait of Hormuz has cut off the vital waterway used to ship 20% of global oil supplies.
“We’re seeing an erosion of growth,” Daco said.
Dr. Tracy Beth Hoeg, the Food and Drug Administration’s top drug regulator, said she was fired from the agency Friday after she declined to resign.
She said she did not know who had ordered her firing or why, nor whether Health Secretary Robert F. Kennedy Jr. knew of her fate. The Department of Health and Human Services did not immediately respond to a request for comment.
The departure reflected the upheaval at the F.D.A., days after the resignation of Dr. Marty Makary, the agency commissioner. Dr. Makary had become a lightning rod for critics of the agency’s decisions to reject applications for rare disease drugs and to delay a report meant to supply damaging evidence about the abortion drug mifepristone. He also spent months before his departure pushing back on the White House’s requests for him to approve more flavored vapes, the reason he ultimately cited for leaving.
Dr. Hoeg’s hiring had startled public health leaders who were familiar with her track record as a vaccine skeptic, and she played a leading role in some of the agency’s most divisive efforts during her tenure. She worked on a report that purportedly linked the deaths of children and young adults to Covid vaccines, a dossier the agency has not released publicly. She was also the co-author of a document describing Mr. Kennedy’s decision to pare the recommendations for 17 childhood vaccines down to 11.
But in an interview on Friday, Dr. Hoeg said she “stuck with the science.”
“I am incredibly proud of the work we were doing,” Dr. Hoeg said, adding, “I’m glad that we didn’t give in to any pressures to approve drugs when it wasn’t appropriate.”
As the director of the agency’s Center for Drug Evaluation and Research, she was a political appointee in a role that had been previously occupied by career officials. An epidemiologist who was trained in the United States and Denmark, she worked on efforts to analyze drug safety and on a panel to discuss the use of serotonin reuptake inhibitors, the most widely prescribed class of antidepressants, during pregnancy. She also worked on efforts to reduce animal testing and was the agency’s liaison to an influential vaccine committee.
She made sure that her teams approved drugs only when the risk-benefit balance was favorable, she said.
The firing worsens the leadership vacuum at the F.D.A. and other agencies, with temporary leaders filling the role of commissioner, food chief and the head of the biologics center, which oversees vaccines and gene therapies. The roles of surgeon general and director of the Centers for Disease Control and Prevention are also unfilled.
-
Hawaii5 minutes agoOdds of El Nino forming this summer increase – West Hawaii Today
-
Idaho11 minutes agoOPINION: Small numbers will make huge decisions in Idaho
-
Illinois17 minutes agoRising 2027 wide receiver marks Illinois football as first official visit
-
Indiana23 minutes agoPossible recounts of tight state Senate races could extend into July
-
Iowa29 minutes agoIowa’s most popular baby names of 2025 start with O and C
-
Kansas35 minutes agoThese are the 5 most beautiful Gothic churches in Kansas
-
Kentucky41 minutes agoOn This Day, May 17: Aristides wins first Kentucky Derby – UPI.com
-
Louisiana47 minutes agoRepublican Senator Cassidy loses Louisiana primary after opposing Trump
